Posts tagged as: CDXC news back to homepage
 |
ChromaDex Launches Aggressive Marketing Campaign for BluScience(0) A new multi-million national media campaign has been launched by Irvine, California’s ChromaDex Corporation (OTCBB:CDXC) for its recently commercialized BluScience™ line of dietary supplements. The help facilitate the media blitz – which will include television, radio and digital outlets – ChromaDex has retained RJ Palmer, a NYC-based full service media agency with billings in excess of $800 million. RJ Palmer, a subsidiary of Read More |
 |
ChromaDex Corp. Video Stock Chart Analysis(0) The ChromaDex Corp. (OTCBB:CDXC) stock chart is on the rise in the New Year. A strong MACD/PPS positive divergence is happening as the Relative Strength Index (RSI) is showing momentum coming into the play. The bottom support at 50 cents must hold on any pullback in share price. Read More |
OTCBB News
read more
Stay Informed
Dana-Farber to Host Cellceutix Trials
Diabetes Rate Growing Exponentially
According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.
